June 10, 2016
(PhysOrg) – As the promise of using regenerative stem cell therapies draws closer, a consortium of biomedical scientists reports about 30 percent of induced pluripotent stem cells they analyzed from 10 research institutions were genetically unstable and not safe for clinical use. In a study published June 9 by the journal Stem Cell Reports, and funded by the National Heart, Lung, and Blood Institute, the multi-institutional research team reports on the comprehensive characterization of a large set of induced pluripotent stem cells (iPSCs). Specialized iPSCs are reprogrammed from adult skin or infant cord blood cells and can become any cell type in the body – a condition called pluripotency that mimics the function of human embryonic stem cells (hESCs).
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.